Laboratory Models of Hepatitis B and D Viruses: Search for Cell Permissiveness and Restriction Factors

Hepatitis B virus (HBV) is an oncogenic human pathogen that accounts for 250 mln cases of chronic hepatitis worldwide. Hepatitis delta virus (HDV) is its satellite that substantially aggravates liver disease. The development of new antivirals and the investigation of viral pathogenesis are limited by the absence of effective cellular and animal models. Current cell models are based on human primary hepatocytes, liver progenitor HepaRG cells, iPS-derived hepatocyte-like cells or various hepatoma cells overexpressing the putative NTCP receptor. However, in most of these models, a majority of cells are non-permissive. In this review, we briefly assess these models, summarize the approaches to the increasing infection rates, and discuss the data on proviral and antiviral (restriction) host factors. The data discussed suggest that rates of HBV and HDV infections are limited by hepatocyte polarization and insufficient expression of the NTCP receptor, as well as the existence of additional co-receptors and restriction factors that can act mostly on the virus entry stage.

Authors

Institutions

Publication Details

Journal
Viruses
Published
2026-11-16
DOI
https://doi.org/10.3390/v18111273
Primary Topic
Hepatitis B Virus Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Laboratory Models of Hepatitis B and D Viruses: Search for Cell Permissiveness and Restriction Factors

Vladimir Chulanov, Olga N. Ivanova, Dmitry S. Kostyushev, Alexander V. Ivanov et al.
Viruses
Hepatitis B Virus Studies
article

Laboratory Models of Hepatitis B and D Viruses: Search for Cell Permissiveness and Restriction Factors

Vladimir Chulanov, Olga N. Ivanova, Dmitry S. Kostyushev, Alexander V. Ivanov, Artemiy P. Fedulov
article en

Abstract

Hepatitis B virus (HBV) is an oncogenic human pathogen that accounts for 250 mln cases of chronic hepatitis worldwide. Hepatitis delta virus (HDV) is its satellite that substantially aggravates liver disease. The development of new antivirals and the investigation of viral pathogenesis are limited by the absence of effective cellular and animal models. Current cell models are based on human primary hepatocytes, liver progenitor HepaRG cells, iPS-derived hepatocyte-like cells or various hepatoma cells overexpressing the putative NTCP receptor. However, in most of these models, a majority of cells are non-permissive. In this review, we briefly assess these models, summarize the approaches to the increasing infection rates, and discuss the data on proviral and antiviral (restriction) host factors. The data discussed suggest that rates of HBV and HDV infections are limited by hepatocyte polarization and insufficient expression of the NTCP receptor, as well as the existence of additional co-receptors and restriction factors that can act mostly on the virus entry stage.

VirusesVol. 18(11)
Engelhardt Institute of Molecular Biology (RU), Russian Academy of Sciences (RU), Sechenov University (RU)
Russian Science Foundation
Good health and well-being
Hepatitis B Virus Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon